Legal Help for Fourniers Gangrene Victims

 If you used diabetes medications popularly known as SGLT2 inhibitors you may have been put at risk of suffering a rare but life-threatening infection of the genitals and genitals area called Fournier’s gangrene.

The danger is so acute that the Food and Drug Administration has issued a public warning to consumers and is requiring the drugs’ manufacturers to add information about this serious risk to all prescribing information and the patient medication guide.

Some of the most popular SGLT2 inhibitors are Invokana, Farxiga, and Jardiance and after the FDA’s warning the national network of attorneys at Injury Help Desk  have reached out to affected patients with offers of free legal consultations about possible compensation.

If you or a loved one developed Fournier’s gangrene after taking a SGLT2 inhibitor to treat diabetes please click on the link to Injury Help Desk for access to information about your legal rights. Please be aware that there may be legal time limits involved in the filing of a claim or lawsuit so contact us immediately.

The FDA said Fournier’s gangrene is an extremely rare but life-threatening bacterial infection of the tissue under the skin that surrounds muscles, nerves, fat, and blood vessels of the perineum.

The bacteria usually get into the body through a cut or break in the skin, where they quickly spread and destroy the tissue they infect. The agency said having diabetes is a risk factor for developing Fournier’s gangrene.

Here is a list of FDA-Approved SGLT2 Inhibitors:
  • Brand Name/Active Ingredient(s)
  • Invokana/canagliflozin
  • Invokamet/canagliflozin and metformin
  • Invokamet XR/canagliflozin and metformin extended-release
  • Farxiga/dapagliflozin
  • Xigduo XR/dapagliflozin and metformin extended-release
  • Qtern /dapagliflozin and saxagliptin
  • Jardiance/empagliflozin
  • Glyxambi/empagliflozin and linagliptin
  • Synjardy/empagliflozin and metformin
  • Synjardy XR/empagliflozin and metformin extended-release
  • Steglatro/ertugliflozin
  • Segluromet/ertugliflozin and metformin
  • Steglujan/ertugliflozin and sitagliptin
The FDA also issued the following recommendations to patients and health care professionals:

Patients should seek medical attention immediately if you experience any symptoms of tenderness, redness, or swelling of the genitals or the area from the genitals back to the rectum, and have a fever above 100.4 F or a general feeling of being unwell. These symptoms can worsen quickly, so it is important to seek treatment right away.

Health care professionals should assess patients for Fournier’s gangrene if they present with the symptoms described above. If suspected, start treatment immediately with broad-spectrum antibiotics and surgical debridement if necessary. Discontinue the SGLT2 inhibitor, closely monitor blood glucose levels, and provide appropriate alternative therapy for glycemic control.

Free Case Evaluation










* By clicking above, you agree to receive telephone calls, emails, voicemails and text messages by one or more legal service providers, even if you are on the “Do Not Call” registry, for the purposes of determining case qualification. You also agree that you are not currently represented by another lawyer for your legal matter. I understand I may revoke my consent to be contacted at any time and that my information is not sold or disclosed other than the purpose to determine the viability of my claim. Injury Help Desk is a matching service only and is not otherwise affiliated with or responsible for the representations or services provided by companies with which you are matched. Legal services for your matter may not be available in all states. All calls are confidential. Prior results do not guarantee a similar outcome. Free background information is available upon request. I freely submit my information and agree to be contacted by one or more members of the legal team to determine whether I might qualify to participate in this lawsuit.